XML 12 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Income Statement [Abstract]        
Net sales $ 257.8 $ 209.3 $ 746.4 $ 641.2
Cost of products sold 182.0 146.2 530.9 447.7
Gross profit 75.8 63.1 215.5 193.5
Selling expense 8.1 6.0 24.6 18.8
Research expense 3.9 4.2 12.9 12.9
General expense 23.8 20.8 69.2 57.9
Total nonmanufacturing expenses 35.8 31.0 106.7 89.6
Restructuring and impairment expense 1.5 1.3 4.2 4.0
Operating profit 38.5 30.8 104.6 99.9
Interest expense 7.4 3.9 20.0 12.6
Other income, net 4.1 0.7 3.2 4.0
Income from continuing operations before income taxes and income from equity affiliates 35.2 27.6 87.8 91.3
Provision for income taxes 9.5 10.7 26.5 27.9
Income (Loss) from Equity Method Investments 0.0 1.8 0.4 2.4
Income from continuing operations 25.7 18.7 61.7 65.8
Income from discontinued operations 0.1 0.0 0.1 0.0
Net income $ 25.8 $ 18.7 $ 61.8 $ 65.8
Net income per share - basic:        
Income per share from continuing operations (in dollars per share) $ 0.84 $ 0.62 $ 2.02 $ 2.16
Income (loss) per share from discontinued operations (in dollars per share) 0.00 0.00 0.00 0.00
Net income per share - basic (in dollars per share) 0.84 0.62 2.02 2.16
Net income per share – diluted:        
Income per share from continuing operations (in dollars per share) 0.84 0.61 2.01 2.15
Income (loss) per share from discontinued operations (in dollars per share) 0.00 0.00 0.00 0.00
Net income per share - diluted (in dollars per share) $ 0.84 $ 0.61 $ 2.01 $ 2.15
Weighted average shares outstanding:        
Basic (in shares) 30,422,800 30,316,400 30,400,400 30,308,200
Diluted (in shares) 30,569,500 30,458,800 30,534,700 30,443,100